Int J Pharm Pharm Sci, Vol 15, Issue 2, 54-59Original Article

EVALUATION OF CARICA PAPAYA LEAF EXTRACT IN PLATELET PROPAGATION FROM STEM CELLS

ADARSH D. B.1, CHANDRA SAGAR K.1, ELANGO E. MURUGAIAN1,2*

1Genelon Institute of Life Sciences, Bangalore, India, 2Evergreen Biosolutions, Hosur, India
Email: elango.em@gmail.com

Received: 13 Nov 2022, Revised and Accepted: 26 Dec 2022


ABSTRAC

Objective: To evaluate the efficiency of Carica papaya extract in differentiating stem cells into platelets.

Methods: The bioactive compounds of C. papaya leaf extract were screened by biochemical and LCMS-MS methods. Mesenchymal stem cells (MSCs) were cultured with and without C. papaya leaf extract and observed for megakaryocyte-mediated platelet differentiation. The microscopy and flow cytometer analysis were performed from day 0 to day 12.

Results: The biochemical and LCMS-MS screening of C. papaya leaf extract confirmed the presence of alkaloids, saponins, glycosides, steroids, flavonoids, phlobatanins and anthracyanine. When treated with leaf extract (50µg), the MSCs differentiated into megakaryocytes and platelets.

Conclusion: The present study has shown the effect of C. papaya leaf extract in MSCs differentiating into platelets. Since the crude extract of the leaf was used, the bioactive compound(s) responsible for platelet production is yet to be confirmed.

Keywords: Platelet production, Carica papaya leaf extract, Dengue virus, Alkaloids and flavonoids


INTRODUCTION

Carica papaya, a herbaceous plant belonging to the Caricaceae family, is one of the most popular and economically important plants in the world as a food source and is widely used as a traditional medicinal plant for treating various diseases [1]. Traditionally papaya plants have been used as anthelmintic, digestive disorders, diarrhoea, skin diseases, male contraceptives, and raw materials for cold [2-4]. Carica papaya contains the enzyme papain in the fruits, stems and leaves. Phytochemicals in C. papaya have been shown to increase the immune system and promote the release of natural chemicals with antitumor activity [5]. The mature leaf concentrate from the Sri Lankan wild-type cultivar of C. papaya modulates both the nonfunctional and functional immune responses of Wistar rats [6].

Thrombocytopaenia management during common and potentially life-threatening dengue infection is considered the most important clinical finding on the efficacy of C. papaya leaf [7]. The methanol extract of C. papaya leaf has been shown to have many phenolic compounds with antioxidant properties [8]. In addition, the alkaloid carpaine was reported to be a significant contributor to anti-thrombocytopaenic properties [9]. It has been demonstrated that the leaf extract of C. papaya augmented platelet count in various dengue fever models in animals, along with reduced clotting time in thrombocytopenic rats [10, 11]. The mature leaf concentrate of C. papaya of the red lady cultivar grown in Sri Lanka increased the platelet and total white blood cells (WBC) activity in hydroxyurea-induced thrombocytopenic Wistar rat model as well as in normal counterpart rats [12].

Embryonic stem cells (ES) are pluripotent cells derived from preimplantation embryos. ES cells can be maintained in culture indefinitely as undifferentiated cells, which can form more differentiated cell types and organs [13, 14]. Human ES cells provide a unique, homogenous, unlimited starting population for studying human hematopoiesis. Human ES cells can be cultured for at least 300 populations without observed senescence while maintaining normal karyotypes, telomere lengths and pluripotency. Moreover, these cells can be cloned from a single cell without losing pluripotency [15, 16]. Human ES cells give rise to differentiated cells and tissues or teratomas in immunodeficient mice or embryoid bodies in vitro [17]. Mouse and human ES cells differ in morphology, population doubling time and growth factor requirements [18, 19]. Mouse ES cells can be maintained as undifferentiated "feeder-independent" cells if growth factors such as leukaemia inhibitory factor (LIF) or related cytokines are added to the media. When human ES cells are grown without feeder cells and with LIF, they either differentiate or die.

Hematopoiesis is sustained by a pool of hematopoietic stem cells (HSCs) which are extensively self-renewed and differentiated into hematopoietic progenitor cells (HPCs) [20]. HPCs are committed to specific lineage and are functionally defined as colony-forming units (CFUs) or burst-forming units (BFUs), i.e., HPCs of the erythroid series (BFU-E, CFU-E), the megakaryocytic lineage (BFU-MK, CFU-MK), the granulocytes-monocytic series (CFU-GM) [21, 22]. Early HPCs also circulate in peripheral blood. Thrombopoietin (TPO) regulates the production of megakaryocytes when platelets are below the normal level. TPO cytokines bind with the TPO receptor, activate JAK and STAT pathways, and stimulate the production of megakaryocytes [23].

The extract from C. papaya leaves increased plasma monocyte chemoattractant protein-1 (MCP-1) levels during the peak of viremia when given orally to AG129 dengue-infected mice. This suggested the possible immunomodulatory capacity of this plant during DENV infection [24].

Clinical studies have shown that C. papaya leaf extract increased platelet counts in patients suffering from dengue [25-27]. Papaya leaves contain phenolic compounds, papain and alkaloids, and these nutrients act as potent antioxidants, enhancing the body's immunity. In addition, acetogenin, a compound found in papaya leaves, helps prevent diseases like malaria and dengue. However, dengue fever is one of the major vector-borne diseases, and appropriate prevention and control measures based on natural products have yet to be developed. Therefore, this study evaluated the action of C. papaya leaf extract on stem cell differentiation into platelet.

MATERIALS AND METHODS

Materials

The young leaves of Carica papaya were collected from the Somwarpet town area in Karnataka, India and washed with distilled water to remove contamination. Then, they were air-dried, cut into pieces, pulverized into powder and stored in a polyethylene bag. The powder (45g) was extracted with 350 ml of solvent (water/methanol/ethanol) in a soxhlet apparatus. The final concentrate was evaporated, and 2.5g of final powder was obtained. 2.5 mg was dissolved in 2.5 ml water (1 mg/ml) and used for analysis.

The chemicals acetic acid, chloroform, ferric chloride (FeCl3), sulfuric acid (H2SO4), hydrochloric acid (HCl) were purchased from Qualigens Fine Chemicals, India.

Phytochemical qualitative analysis

The phytochemical analysis was performed by standard methods [28-31].

Test for saponins: Distilled water was mixed and added to an aqueous extract (1 mg/ml) and mixed vigorously. The frothing obtained was mixed with a few drops of olive oil and mixed vigorously. The appearance of the foam showed the presence of saponins.

Tests for glycosides

Liebermann’s test: Acetic acid and chloroform (1:1 v/v) was added to aqueous extract (1 mg/ml). This mixture was then cooled and added with concentrated H2SO4. The green colour represented the entity of aglycone, a steroidal part of glycosides.

Keller-kiliani test: Glacial acetic acid and 2.0% FeCl3 mixture (4:1) was mixed with the aqueous plant extract (1 mg/ml) and conc. H2SO4. Cardiac steroidal glycosides exhibited a brown ring formed between the layers.

Salkowski’s test: Conc. H2SO4 was added to an aqueous plant extract (1 mg/ml). A reddish brown colour formed, which indicated the presence of steroidal aglycone part of the glycoside.

Test for steroids: Chloroform and conc. H2SO4 (20:1) was added to aqueous plant extract (1 mg/ml). In the lower chloroform layer, the red colour appeared, indicating the presence of steroids.

Test for tannins: 5% ferric chloride was added to aqueous plant extract (1 mg/ml). The formation of dark blue or greenish black indicates the presence of tannins.

Test for Alkaloids

Wagner’s test: Diluted HCl and Wagner's reagent were added to aqueous plant extract (1 mg/ml) and shaken well.

Test for flavonoids: 2N sodium hydroxide was added to aqueous plant extract (1 mg/ml). The presence of yellow colour indicates the presence of flavonoids.

Test for quinones: Conc. H2SO4 was added to an aqueous plant extract (1 mg/ml). The red colour indicates the presence of quinones.

Test for phenols: Distilled water and a few drops of 10% FeCl3 were added to aqueous plant extract (1 mg/ml). The formation of blue or green colours indicates the presence of phenols.

Test for terpenoids: Aqueous plant extract (1 mg/ml) was treated with chloroform and conc. H2SO4. The formation of red-brown colour at the interface indicates the presence of terpenoids.

Test for coumarins: 10% sodium hydroxide was added to aqueous plant extract (1 mg/ml). The appearance of yellow colour indicates the presence of coumarins.

Test for anthraquinones: 10% ammonia solution was added to aqueous extract (1 mg/ml), and the appearance of a pink precipitate indicates the presence of anthraquinones.

Test for phlobatannins: 2% hydrochloric acid was added to the aqueous extract (1 mg/ml). The appearance of a red colour precipitate indicates the presence of phlobatannins.

Test for anthracyanine: 2N sodium hydroxide was added to aqueous extract (1 mg/ml) and heated for 5 min at 100 °C. The formation of bluish-green colour indicates the presence of anthocyanin.

LCMS-MS analysis of papaya leaf extract

The C. papaya leaf extracts (1 mg/ml) (aqueous, ethanol and methanol) were subjected to LCMS-MS (Shimadzu 8050) analysis. The parameters were: Esi mode, solvent methanol, mobile phase A-5 mm ammonium formate, Mobile phase B-Methanol, injection volume 10 µl. In the graph obtained, individual peaks were compared with available literature for compound identification. The compounds thus identified were compared and tabulated.

Preparation of aqueous extract of C. papaya leaf for cell culture

Middle-aged, fresh C. papaya leaves were collected, washed and dried under shade. Of the dried leaves, the middle stems were removed, and the rest were crushed using a mortal and pestle. The crushed powder of 45 grams was added to 350 ml of distilled water and kept for 16 h at 60 °C. This extract was cooled, filtered and used for cell culture experiments.

Culture of mesenchymal stem cells

Vented tissue culture flasks (25 cm2) with 10 ml Dulbecco’s modified Eagles medium (DMEM) with 10% fetal calf serum (FCS) were seeded with 1X107 cells for primary culture. The flasks were incubated at 37 °C in a humidified atmosphere containing 5% CO2 and were given by half MSC medium change every week until the fibroblast-like cells at the base of the flask reached confluence.

Culture of mesenchymal stem cells by addition of C. papaya leaf extract

Bone Marrow Stem cells were cultured in DMEM supplemented with Fetal Bovine Serum (10%) and 50 µl of C. papaya leaf extract (1 mg/ml) in the presence of antibiotics (Penicillin-Streptomycin, 1%). Cells were incubated at 37 °C in the presence of 5% CO2. This culture with C. papaya leaf extracts was carried out in quadruple. Cultures without C. papaya leaf extract were considered as controls. From day 0, the cells were observed under the fluorescence microscope, and their morphology and cell count results were documented.

Flow cytometer analysis of platelets derived from MSC cells

The number of platelets produced through MSCs-derived megakaryocytes were determined by flow cytometer using MWReg 30 monoclonal antibody1C2, a platelet-specific antibody. The culture medium was gently collected and centrifuged at 150g for 20 min to remove the large nucleated cells. The supernatant was fixed with 1% paraformaldehyde for 1 hour and centrifuged at 900g for 10 min. Next, the cell pellet was washed with Hanks balanced salt solution with Ca2+(HBSS) containing 1% FBS and incubated with 10g/ml MWReg 30 monoclonal antibody1C2 (Seikagaku, Tokyo, Japan), followed by FITC–goat anti-rat IgG; each incubation was performed on ice for 1 hour. Finally, the cells were washed and analyzed by a flow cytometer. A single platelet gate was created by analyzing adult mouse peripheral platelets similarly.

RESULTS

The qualitative tests were conducted to evaluate the phytochemical profile (alkaloid, tannin, flavonoid, saponins, tannins and Glycoside) of C. papaya leaf extract. The results are presented in table 1. The phytochemical screening of aqueous, ethanolic and methanolic extracts showed the presence of saponins, glycosides, steroids, tannins, flavonoids, quinines, terpenoids, coumarins, phlobatanins and anthraquinones. However, according to the earlier report, phenol was detected only with methanolic extracts [32].

The LCMS-MS analysis of the phytochemicals present in C. papaya leaf extract with their corresponding retention time, molecular formula, molecular weight, and relative abundance are presented in fig. 1 and table 2. The aqueous extract was found to have more compounds, followed by the methanolic extract. Few compounds like flavinoids, alkaloids and quinines are absent in ethanolic extract. Anthracyanine was present in both aqueous and ethanolic extracts.

Table 1: Phytochemical qualitative analysis of Carica papaya leaf extract (1 mg/ml)

S. No. Tests Aqueous Ethanolic Methanolic
1 Saponins + + +
2 Glycosides
Liebermann’s Test - + +
Keller-Kiliani Test - + -
Salkowski’s Test + - -
3 Steroids + + +
4 Tannins + + +
5 Alkaloids
6 Flavonoids + + -
7 Quinones + + +
8 Phenols - - +
9 Terpenoids + - +
10 Cardiac Glycosides + + +
11 Coumarins + + +
12 Anthraquinones - - -
13 Phlobatannins + - +
14 Anthracyanine + - +

Fig. 1: LC-MS chromatogram analysis of A. aqueous, B. ethanol and C. methanol extract of Carica papaya leaf

Table 2: LCMS-MS analysis of aqueous ethanol and methanol extract from Carica papaya leaf

S. No. Tests m/Z (Mass to charge) A (Water) intensity B (Ethanol) intensity C (Methanol) intensity
Absolute Relative Absolute Relative Absolute Relative
1 Saponins 789 (mol. wt-1223.3g/mol)
2

Glycosides

(aglycone)

389 (mol wt-526.5 g/mol) 16297 5.00 8343 5.53
3 Steroids 425 (mol. wt-526.5 g/mol) 16543 7.84 8579= (421.3 m/Z) 5.69= (421.3 m/Z) 492827= (429.45 m/Z) 8.74= (429.45 m/Z)
4 Tannins 371 (mol. wt-636.5 g/mol) 19897= (373.30 m/Z) 6.11= (373.30 m/Z)
5 Alkaloids 319 (mol. wt-g/mol) 17381 5.34 37367= (313.10 m/Z) 7.06 =(313.10 m/Z)
6 Flavonoids 151 (mol. wt-222.24g/mol) 21704 6.08
7 Quinones 189 (mol.-108.09 g/mol) 27956 7.84 41683 =(191 m/Z) 7.87 =(191 m/Z)
8 Phenols 135 (mol. wt-94.11g/mol) 101715 28.51 338784= (133.10 m/Z) 63.97 = (133.10 m/Z)
9 Terpenoids 136 (mol. wt-552.8g/mol) 92418 28.37 559251= (138.10 m/Z) 18.12= (138.10 m/Z) 1193351 = (138.10 m/Z) 21.16= (138.10 m/Z)
10 Cardiac glycosides 591 (mol. wt-780.9g/mol)
11 Coumarins 147 (mol. wt-146.14 g/mol) 26278 7.37 12345 8.18
12 Anthraquinones 270 (mol. wt-208.21 g/mol) 14583= (271 m/Z) 6.92= (271 m/Z) 18532= (266.15 m/Z) 6.00 266.15 185328 6.00 266.15 185328 6.00
13 Phlobatannins 278.118 (mol. wt-g/mol) 19292 9.15 3087055 =(279.20 m/Z) 100.00 =(279.20 m/Z) 54520 10.29
14 Anthracyanine 449 (mol. wt-207.24g/mol) 10673 5.06 16983 =(447.30 m/Z) 11.26 =(447.30 m/Z)

Bone marrow mesenchymal stem cells (MSCs) cultured in DMEM were subjected to platelet differentiation with and without C. papaya leaf extract (fig. 2). In the absence of the extract, the stem cells proliferated into dense colonies and formed a confluence layer without any differentiation during the 12 d study period. However, while exposed to C. papaya leaf extract, the stem cells started differentiating to larger colonies on day 6, progressed to megakaryocytes on day 9 and matured into platelets on day 12.

Fig. 2: Effect of Carica papaya leaf extract in Mesenchymal Stem Cells culture. Mesenchymal Stem Cells were cultured in the presence of C. papaya leaf extract (1 mg/ml) and evaluated against culture without extract. A: Control-MSCs proliferated without any differentiation. B: C. papaya leaf extract triggered the differentiation of MSCs into larger cells. C: MSCs formed uniform monolayer without C. papaya leaf extract. D: The differentiation of MSCs further progressed into larger colonies. E and G: MSCs proliferated into dense colonies and formed a confluence layer. F: The larger colonies progressed into megakaryocytes. H: Maturation of megakaryocytes into platelets

Fig. 3: Flow cytometer analysis of mesenchymal stem cells culture with C. papaya leaf extract. Mesenchymal Stem Cells were cultured in the presence of C. papaya leaf extract (1 mg/ml) and evaluated against culture without the extract. Day 0: A-Control MSCs. B: MSCs exposed to C. papaya leaf extract. Day 9: C-MSCs formed uniform proliferation without C. papaya leaf extract. D: The different MSCs into larger colonies. Day 12:. E-MSCs formed a confluence layer without differentiations. F-Maturated platelets from megakaryocytes

The MSCs treated with C. papaya leaf extract were analyzed by flow cytometer using MWReg 30 monoclonal antibody1C2, a platelet-specific antibody (fig. 3). This further confirmed the differentiation of the MSCs to megakaryocytes and platelets (D and F, respectively) by the extract. However, no differentiation was observed with the MSCs without exposure to C. papaya leaf extract (C and E, respectively).

DISCUSSION

Thrombocytopenia, a critically reduced platelet count, is associated with severe dengue fever, thus, a significant mortality factor [33]. The viral pathogen replicates in platelet, declines platelet production, and destroys the platelets in circulation. Several reports based on the in vitro studies have affirmed an increase in the platelet number with the administration of C. papaya leaf extract [34]. The leaves of C. papaya have been found to have multiple chemical compounds, namely alkaloids, terpenoids, phenols, tannins, flavonoids, saponins and glycosides [7, 9, 35]. Among the phytocompound (s), the alkaloids, particularly the "carpaine" alkaloid, rather than phenolic compounds, are responsible for the anti-thrombocytopenic activity. The present study also identified the compounds as per the earlier reports. As expected, flavonoids and other alkaloids were found to be more and higher in concentration, and the phenol with less amount in aqueous and absent in ethanolic extract.

Treating dengue patients with C. papaya leaf extract has been shown to potentially inhibit intracellular replication of DENV-2 with a significant reduction (p<0.05) in platelet aggregation [26] and also the reversal of peripheral platelet destruction by membrane stabilization [36]. C. papaya leaf flavonoids have been shown to inhibit a protease involved in viral assembly [25]. The saponins were considered to enhance cell-mediated immunity and humoral antibody in animal models [37]. The antioxidants with free radical scavenging properties of papaya leaf extract may significantly prevent hemolysis and bleeding [38]. Most of these studies were on platelet protection or increased production, while studies on stem cell differentiation into platelet are scanty. The present study evaluated the effect of C. papaya leaf extract in bone marrow-derived mesenchymal stem cells differentiation into platelet. The results have delineated that platelets can be generated through the promegakaryocyte pathway by treating the stem cells with C. papaya leaf extract. An earlier report showed that C. papaya leaf extract increased the expression ALOX 12 gene by 15-fold and platelet-activating factor receptor (PTAFR) genes. The expression of these genes increased megakaryocyte production and its conversion into platelets. Activation of the 12-HETE mediated pathway could be the mechanism of action in the production of platelets [39, 40]. It is identified that about 60% of the anticancer compounds occurred in anticancer drugs are derived from herbal sources [41].

CONCLUSION

This study is a preliminary milestone in platelet production by differentiating the stem cells with C. papaya leaf extract. There is a volume of bioactive compounds in C. papaya leaf extract. As supported by earlier studies, many play an essential role in platelet production, protection, and viral pathogen destruction. However, specific compound(s) and their mechanism have not been well established. While most studies were on platelet regeneration and protection under in vivo conditions, stem cell-mediated platelet production has yet to be well studied. We initiated the MSCs differentiation into megakaryocyte-mediated platelets with C. papaya leaf extract in this study. Our study has provided valuable information on the positive effects that stem cells can be used for large-scale platelet production, thus reducing the burden on whole blood-based platelet collection. Further studies are required to delineate the specific compounds and their action on stem cell differentiation into platelets.

ACKNOWLEDGEMENT

The authors thankfully acknowledge NAWaL Analytical Laboratories, Hosur, Tamilnadu, India for the LCMS-MS study on C. papaya leaf extracts

FUNDING

Nil

AUTHORS CONTRIBUTION

This is author’s sole research work and each author has contributed equally. This research work does not have contribution from others.

CONFLICT OF INTERESTS

Declared none

REFERENCES

  1. Carvalho FA, Renner SS. A dated phylogeny of the papaya family (Caricaceae) reveals the crop’s closest relatives and the family’s biogeographic history. Mol Phylogenet Evol. 2012;65(1):46-53. doi: 10.1016/j.ympev.2012.05.019. PMID 22659516.

  2. Kovendan K, Murugan K, Naresh Kumar A, Vincent S, Hwang JS. Bioefficacy of larvicdial and pupicidal properties of Carica papaya (Caricaceae) leaf extract and bacterial insecticide, spinosad, against chikungunya vector, Aedes aegypti (Diptera: Culicidae). Parasitol Res. 2012;110(2):669-78. doi: 10.1007/s00436-011-2540-z, PMID 21750871.

  3. Collard E, Roy S. Improved function of diabetic wound-site macrophages and accelerated wound closure in response to oral supplementation of a fermented papaya preparation. Antioxid Redox Signal. 2010;13(5):599-606. doi: 10.1089/ars.2009.3039, PMID 20095880, PMCID PMC2935338.

  4. Pathak N, Mishra PK, Manivannan B, Lohiya NK. Sterility due to inhibition of sperm motility by oral administration of benzene chromatographic fraction of the chloroform extract of the seeds of Carica papaya in rats. Phytomedicine. 2000;7(4):325-33. doi: 10.1016/S0944-7113(00)80051-3, PMID 10969727.

  5. Otsuki N, Dang NH, Kumagai E, Kondo A, Iwata S, Morimoto C. Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects. J Ethnopharmacol. 2010;127(3):760-7. doi: 10.1016/j.jep.2009.11.024. PMID 19961915.

  6. Jayasinghe CD, Gunasekera DS, De Silva N, Jayawardena KKM, Udagama PV. Mature leaf concentrate of Sri Lankan wild type Carica papaya Linn. modulates nonfunctional and functional immune responses of rats. BMC Complement Altern Med. 2017;17(1):230. doi: 10.1186/s12906-017-1742-z, PMID 28446195, PMCID PMC5406937.

  7. Subenthiran S, Choon TC, Cheong KC, Thayan R, Teck MB, Muniandy PK. Carica papaya Leaves juice significantly accelerates the rate of increase in platelet count among patients with dengue fever and dengue haemorrhagic fever. Evid Based Complement Alternat Med. 2013;2013:616737. doi: 10.1155/2013/616737, PMID 23662145, PMCID PMC3638585.

  8. Canini A, Alesiani D, D’Arcangelo G, Tagliatesta P. Gas chromatography–mass spectrometry analysis of phenolic compounds from Carica papaya L. leaf. J Food Compos Anal. 2007;20(7):584-90. doi: 10.1016/j.jfca.2007.03.009.

  9. Zunjar V, Dash RP, Jivrajani M, Trivedi B, Nivsarkar M. Antithrombocytopenic activity of carpaine and alkaloidal extract of Carica papaya Linn. leaves in busulfan induced thrombocytopenic Wistar rats. J Ethnopharmacol. 2016;181:20-5. doi: 10.1016/j.jep.2016.01.035. PMID 26812680.

  10. Patil SSS, Bhide R, Narayanan S. Evaluation of platelet augmentation activity of Carica papaya leaf aqueous extract in rats. J Pharm Phytochem. 2013;1:57.

  11. Arollado EC, Pena IG, Dahilig VR. Platelet augmentation activity of selected philippine plants. Int J Pharm Phytopharmacol Res. 2014;3:121-3.

  12. Gammulle A RW, Jayakody J, Fernando C, Kanatiwela C, Udagama PV. Thrombocytosis and anti-inflammatory properties, and toxicological evaluation of Carica papaya mature leaf concentrate in a murine model. Online Int J Med Plant Res. 2012;1:21-30.

  13. Hong N, He BP, Schartl M, Hong Y. Medaka embryonic stem cells are capable of generating entire organs and embryo-like miniatures. Stem Cells Dev. 2013;22(5):750-7. doi: 10.1089/scd.2012.0144, PMID 23067146.

  14. Vodyanik MA, Slukvin II. Hematoendothelial differentiation of human embryonic stem cells. Curr Protoc Cell Biol. 2007;Chapter(23):Unit 23.6. doi: 10.1002/0471143030.cb2306s36, PMID 18228507.

  15. Amir H, Touboul T, Sabatini K, Chhabra D, Garitaonandia I, Loring JF. Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival. Stem Cells. 2017;35(4):872-85. doi: 10.1002/stem.2550, PMID 27888558.

  16. Kanatsu Shinohara M, Lee J, Inoue K, Ogonuki N, Miki H, Toyokuni S. Pluripotency of a single spermatogonial stem cell in mice. Biol Reprod. 2008;78(4):681-7. doi: 10.1095/biolreprod.107.066068, PMID 18199882.

  17. Keller GM. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol. 1995;7(6):862-9. doi: 10.1016/0955-0674(95)80071-9, PMID 8608017.

  18. Mu J, Li X, Yuan S, Zhang J, Bo P. Comparative study of directional differentiation of human and mouse embryonic stem cells into cardiomyocytes. Cell Biol Int. 2014;38(10):1098-105. doi: 10.1002/cbin.10302, PMID 24802967.

  19. Fonseca SA, Costas RM, Pereira LV. Searching for naïve human pluripotent stem cells. World J Stem Cells. 2015;7(3):649-56. doi: 10.4252/wjsc.v7.i3.649. PMID 25914771, PMCID PMC4404399.

  20. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993;81(11):2844-53, PMID 8499622.

  21. Kimmerlin Q, Tavian M, Gachet C, Lanza F, Brouard N. Isolation of mouse megakaryocyte progenitors. J Vis Exp. 2021;171(171). doi: 10.3791/62498, PMID 34096917.

  22. Canu G, Ruhrberg C. First blood: the endothelial origins of hematopoietic progenitors. Angiogenesis. 2021;24(2):199-211. doi: 10.1007/s10456-021-09783-9, PMID 33783643, PMCID PMC8205888.

  23. Kuter DJ. The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol. 2013;98(1):10-23. doi: 10.1007/s12185-013-1382-0, PMID 23821332.

  24. Norahmad NA, Mohd Abd Razak MR, Mohmad Misnan N, Jelas Md NH, Sastu UR, Muhammad A. Effect of freeze-dried carica papaya leaf juice on inflammatory cytokines production during dengue virus infection in AG129 mice. BMC Complement Altern Med. 2019;19(1):44. Epub 20190211. doi: 10.1186/s12906-019-2438-3. PubMed PMID: 30744623; PubMed Central PMCID: PMC6371484.

  25. Charan J, Saxena D, Goyal JP, Yasobant S. Efficacy and safety of Carica papaya leaf extract in the dengue: A systematic review and meta-analysis. Int J Appl Basic Med Res. 2016;6(4):249-54. doi: 10.4103/2229-516X.192596, PMID 27857891, PMCID PMC5108100.

  26. Chinnappan S, Ramachandrappa VS, Tamilarasu K, Krishnan UM, Pillai AK, Rajendiran S. Inhibition of platelet aggregation by the leaf extract of Carica papaya during dengue infection: an in vitro study. Viral Immunol. 2016;29(3):164-8. doi: 10.1089/vim.2015.0083, PMID 26910599.

  27. Arollado EC, Pena IG, Dahilig VR. Platelet augmentation activity of selected Philippine plants. Int J Pharm Phytopharmacol Res. 2014;3:121-3.

  28. Hakim RF, Fakhrurrazi, Dinni. Effect of carica papaya extract toward incised wound healing process in mice (Mus musculus) clinically and histologically. Evid Based Complement Alternat Med. 2019;2019:8306519. doi: 10.1155/2019/8306519. PMID 31827564.

  29. Desta W, Shumbahri M, Gebrehiwot S. Application of ficus carica L. and solanum incanum L. extracts in coagulation of milk: the case of traditional practice in Ab’ala Area, Afar Regional State, Ethiopia. Biochem Res Int. 2020;2020:9874949. doi: 10.1155/2020/9874949, PMID 32322421, PMCID PMC7166260.

  30. Sasidharan S, Chen Y, Saravanan D, Sundram KM, Yoga Latha L. Extraction, isolation and characterization of bioactive compounds from plants’ extracts. Afr J Tradit Complement Altern Med. 2011;8(1):1-10. doi: 10.4314/ajtcam.v8i1.60483, PMID 22238476, PMCID PMC3218439.

  31. Ghosal M, Mandal P. Phytochemical screening and antioxidant activities of two selected ”Bihi” fruits used as vegetables in Darjeeling Himalaya. Int J Pharm Pharm Sci. 2012;4(2):567-74.

  32. Canini A, Alesiani D, D’Arcangelo G, Tagliatesta P. Gaschromatography–mass spectrometry analysis of phenolic compounds from Carica papaya L. leaf. J Food Compos Anal. 2007;20(7):584-90. doi: 10.1016/j.jfca.2007.03.009.

  33. Sarker MMR, Khan F, Mohamed IN. Dengue fever: therapeutic potential of Carica papaya L. leaves. Front Pharmacol. 2021;12:610912. doi: 10.3389/fphar.2021.610912, PMID 33981215, PMCID PMC8109180.

  34. Rajapakse S, de Silva NL, Weeratunga P, Rodrigo C, Sigera C, Fernando SD. Carica papaya extract in dengue: a systematic review and meta-analysis. BMC Complement Altern Med. 2019;19(1):265. doi: 10.1186/s12906-019-2678-2, PMID 31601215, PMCID PMC6788024.

  35. Patil S, Shetty S, Bhide R, Narayanan S. Evaluation of platelet augmentation activity of Carica papaya leaf aqueous extract in rats. J Pharm Phytochem. 2013;1:57.

  36. Ranasinghe P, Ranasinghe P, Abeysekera WP, Premakumara GA, Perera YS, Gurugama P. In vitro erythrocyte membrane stabilization properties of Carica papaya L. leaf extracts. Pharmacognosy Res. 2012;4(4):196-202. doi: 10.4103/0974-8490.102261. PMID 23225962.

  37. Ojiako CM, Okoye EI, Oli AN, Ike CJ, Esimone CO, Attama AA. Preliminary studies on the formulation of immune stimulating complexes using saponin from Carica papaya leaves. Heliyon. 2019;5(6):e01962. doi: 10.1016/j.heliyon.2019.e01962, PMID 31294113, PMCID PMC6595190.

  38. Pandita A, Mishra N, Gupta G, Singh R. Use of papaya leaf extract in neonatal thrombocytopenia. Clin Case Rep. 2019;7(3):497-9. doi: 10.1002/ccr3.2025, PMID 30899480, PMCID PMC6406160.

  39. Sundarmurthy D, RJ, CL. Effect of Carica papaya leaf extract on platelet count in chemotherapy-induced thrombocytopenic patients: a preliminary study. Natl J Physiol Pharm Pharmacol. 2017;7(6):1. doi: 10.5455/njppp.2017.7.0202628022017.

  40. Sarker MMR, Khan F, Mohamed IN. Dengue fever: therapeutic potential of Carica papaya L. Leaves. Front Pharmacol. 2021;12:610912. doi: 10.3389/fphar.2021.610912, PMID 33981215, PMCID PMC8109180.

  41. Renuka Srihari. Evaluating the cytotoxic potential of methanolic leaf extract of Aleo vera on MCF-7 breast cancer cell lines. IJPPS. 2015. ISSN-0975-1491.